PolyPid Ltd. (PYPD) Misses Q4 EPS by 39c

PolyPid Ltd. (NASDAQ: PYPD) reported Q4 EPS of ($3.97), $0.39 worse than the analyst estimate of ($3.58).

For earnings history and earnings-related data on PolyPid Ltd. (PYPD) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
• Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65